Population
Adult mammals with end-stage diseased hearts and cardiomyocyte loss
Design
Review
Authors
Loading...
Not ready for clinical use in heart failure; leaves open whether regulatory proteins or grafting can achieve meaningful regeneration.
Myocardial regeneration through regulatory protein expression or exogenous cardiomyocyte grafting represents a potential future therapeutic approach for end-stage heart disease.
Soonpaa et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: